| 초록 |
Many nanomaterials are being harnessed as critical components in various systems for biomedical applications including diagnosis, imaging, and drug delivery. Those systems necessitate biocompatibility and low toxcity within effective dose range while achieving enough efficacy. Even though many nanomaterials enjoy successful demonstrations in bioapplications, lack of biocompatibility and robustness often become hurdles for practical bioapplications. On the other hand, it is important to understand mechanism at molecular level based on chemically well-defined systems for designing better biotechnological systems. In this talk, I will introduce recent efforts to utilize “graphene” for bioanalytical platforms, especially in enzyme activity assay, which can be further harnessed for drug screening. In addtion, cellular responses of mammalian cells to graphene will be discussed to explore new opportunities of graphene in biotechnology. |
